Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 2.333
Filter
Add more filters

Publication year range
1.
Virol J ; 21(1): 39, 2024 02 09.
Article in English | MEDLINE | ID: mdl-38336670

ABSTRACT

Pneumonia is the most common complication of varicella infections. Although previous studies have tended to focus mainly on immunocompromised patients, varicella pneumonia can also occur in healthy adults. Therefore, in this study, we aimed to assess the progression of varicella pneumonia in immunocompetent hosts. This retrospective study involved immunocompetent adult outpatients with varicella who attended the adult Fever Emergency facility of Peking University Third Hospital from April 1, 2020, to October 31, 2022. Varicella pneumonia was defined as a classic chickenpox-type rash in patients with infiltrates on chest computed tomography. The study included 186 patients, 57 of whom had a contact history of chickenpox exposure. Antiviral pneumonia therapy was administered to 175 patients by treating physicians. Computed tomography identified pneumonia in 132 patients, although no deaths from respiratory failure occurred. Seventy of the discharged patients were subsequently contacted, all of whom reported being well. Follow-up information, including computed tomography findings, was available for 37 patients with pneumonia, among whom 24 reported complete resolution whereas the remaining 13 developed persistent calcifications. Notably, we established that the true incidence of varicella pneumonia is higher than that previously reported, although the prognosis for immunocompetent hosts is generally good.


Subject(s)
Chickenpox , Pneumonia, Viral , Adult , Humans , Chickenpox/complications , Chickenpox/epidemiology , Retrospective Studies , Prevalence , Pneumonia, Viral/complications , Pneumonia, Viral/epidemiology , Immunocompetence , Herpesvirus 3, Human
2.
BMC Infect Dis ; 24(1): 691, 2024 Jul 11.
Article in English | MEDLINE | ID: mdl-38992583

ABSTRACT

BACKGROUND: Hemorrhagic varicella (HV) is a particular form of chicken pox.,with high mortality in adults. This form of the disease is rare, to date, approximately 4 cases have been reported. Occasional cases of HV have been documented in adults with hematologic disorders or other diseases. While there is one reported case of simultaneous reactivation of cytomegalovirus in an adult with chickenpox, there is a lack of information regarding changes in liver function indicators for such patients. This is unfortunate, as CMV reactivation can further exacerbate liver failure and increase mortality. In this report, we present a case of hemorrhagic varicella reactivation with cytomegalovirus and provide some relevant discussions. CASE PRESENTATION: We present the case of a 25-year-old male with HV, who had a history of nephrotic syndrome generally controlled with orally administered prednisone at a dosage of 50 mg per day for two months. The patient arrived at the emergency room with complaints of abdominal pain and the presence of hemorrhagic vesicles on his body for the past 3 days. Despite medical evaluation, a clear diagnosis was not immediately determined. Upon admission, the leukocyte count was recorded as 20.96 × 109/L on the first day, leading to the initiation of broad-spectrum antibiotic treatment. Despite the general interpretation that a positive IgG and a negative IgM indicate a previous infection, the patient's extraordinarily elevated IgG levels, coupled with a markedly increased CMV DNA quantification, prompted us to suspect a reactivation of the CMV virus. In light of these findings, we opted for the intravenous administration of ganciclovir as part of the treatment strategy. Unfortunately,,the patient succumbed to rapidly worsening symptoms and passed away. Within one week of the patient's demise, chickenpox gradually developed in the medical staff who had been in contact with him. In such instances, we speculate that the patient's diagnosis should be classified as a rare case of hemorrhagic varicella. CONCLUSION: Swift identification and timely administration of suitable treatment for adult HV are imperative to enhance prognosis.


Subject(s)
Chickenpox , Coinfection , Cytomegalovirus Infections , Cytomegalovirus , Humans , Male , Adult , Cytomegalovirus Infections/drug therapy , Cytomegalovirus Infections/complications , Cytomegalovirus Infections/virology , Cytomegalovirus Infections/diagnosis , Cytomegalovirus/isolation & purification , Chickenpox/drug therapy , Chickenpox/complications , Chickenpox/virology , Chickenpox/diagnosis , Coinfection/virology , Coinfection/drug therapy , Antiviral Agents/therapeutic use , Antiviral Agents/administration & dosage , Hemorrhage/virology , Hemorrhage/etiology , Herpesvirus 3, Human/isolation & purification , Virus Activation
3.
Am J Dermatopathol ; 46(3): 159-161, 2024 Mar 01.
Article in English | MEDLINE | ID: mdl-38354383

ABSTRACT

ABSTRACT: Hemorrhoids are normal anatomical structures in the anus. When symptomatic, they prompt medical attention due to pain, rectal bleeding, and discomfort. Treatment includes dietary modifications, rubber band ligations, sclerotherapy, cryotherapy, or hemorrhoidectomy. Histologic examination is important to rule out incidental findings, such as perianal intraepithelial neoplasia, anal carcinoma, melanoma, or coexisting infections. Special attention should be given when patient is immunocompromised. We present a case of a 41-year-old man with a history of ulcerative colitis on adalimumab who presented with anal lesions. He was diagnosed with hemorrhoids and surgically treated. Microscopic examination confirmed the diagnosis of hemorrhoids. However, foci of epithelium with viral cytopathic effects were noted. A varicella zoster virus (VZV)-specific immunostain was positive in the areas of interest confirming the diagnosis of the VZV infection limited to the hemorrhoids. Combined herpes simplex virus type 1 and 2 (HSV 1 and HSV 2) immunostain was also performed and was negative. Anal herpes has been widely described in the literature, particularly in immunocompromised patients. However, isolated VZV infection in hemorrhoids to the best of our knowledge has never been reported.


Subject(s)
Chickenpox , Colitis, Ulcerative , Hemorrhoids , Herpes Zoster , Male , Humans , Adult , Hemorrhoids/complications , Hemorrhoids/diagnosis , Chickenpox/complications , Herpesvirus 3, Human , Colitis, Ulcerative/complications
4.
Curr Opin Infect Dis ; 36(2): 109-113, 2023 04 01.
Article in English | MEDLINE | ID: mdl-36718910

ABSTRACT

PURPOSE OF REVIEW: Skin rashes seen during COVID-19 usually feature maculopapular or vesicular morphology, thus mimicking cutaneous eruptions occurring in other common infectious dermatoses, such as mononucleosis, chickenpox, sixth disease and measles, with possible diagnostic mistakes. In this review article, we sought to provide a practical overview about clinical appearance of skin rashes related to SARS-CoV-2 infection. RECENT FINDINGS: The study summarizes literature evidence on clinical patterns of COVID-19-associated maculopapular or vesicular rash, with a particular emphasis on the principal points of differentiation with possible mimickers. SUMMARY: Several differences do exist between rashes due to SARS-CoV-2 infection and other viral eruptions, mainly including lesions morphology, spreading pattern, symptoms and mucosal involvement. The increase of awareness of such features among clinicians may help promptly recognize COVID-19-related exanthemas in order to take proper action to manage the infection.


Subject(s)
COVID-19 , Chickenpox , Exanthema Subitum , Exanthema , Measles , Skin Diseases , Humans , COVID-19/diagnosis , COVID-19/complications , Exanthema Subitum/complications , SARS-CoV-2 , Chickenpox/complications , Chickenpox/diagnosis , Exanthema/etiology , Exanthema/complications , Measles/complications , Measles/diagnosis , Skin Diseases/complications , Skin Diseases/diagnosis
5.
J Med Virol ; 95(9): e29108, 2023 09.
Article in English | MEDLINE | ID: mdl-37715715

ABSTRACT

Live varicella vaccines are known to provide robust immunity against varicella zoster virus (VZV) infections. However, problems with viral attenuation have led to pathogenic VZV vaccine strains causing varicella-like rash and herpes zoster in immunocompetent children after immunization. We report the first fatal case of VZV infection caused by OKA/SK strain contained in the vaccine administrated as a booster shot in an immunocompetent child, which has been independently developed from any currently available varicella vaccines that are OKA strain or MAV/06 strain based. The patient died due to sudden pulmonary alveolar hemorrhage as a secondary complication of VZV pneumonitis. Sequencing of the four SNPs unique to the OKA/SK strain (SNP loci 14 035T; 32 626C; 58 777G; 70 319G) enabled discrimination of the strain responsible for the disseminated infection. OKA/SK strain does not have any SNPs in ORF62 postulated to be responsible for the attenuation of varicella vaccines which have been safely and effectively used world-wide or locally, and exclusively enriches a virulent factor in ORF31 identified in parental OKA strain, thus possibly resulting in disseminated VZV infection leading to mortality. Therefore, actions need to be taken to prevent vaccine related morbidity and mortality in children.


Subject(s)
Chickenpox , Herpes Zoster Vaccine , Herpes Zoster , Viral Vaccines , Child , Humans , Chickenpox/complications , Chickenpox Vaccine/adverse effects , Vaccines, Attenuated , Antigens, Viral
6.
J Neurovirol ; 29(4): 449-459, 2023 08.
Article in English | MEDLINE | ID: mdl-37219811

ABSTRACT

Varicella-zoster virus (VZV) infection may cause vascular inflammatory changes leading to an increased risk of stroke. Previous studies have focused on the risk of stroke and less on changes in stroke risk and prognosis. We aimed to explore the changing patterns of stroke risk and stroke prognosis after VZV infection. This study is a systematic review and meta-analysis. We searched PubMed, Embase, and the Cochrane Library for studies on stroke after VZV infection between January 1, 2000, and October 5, 2022. Relative risks were combined for the same study subgroups using a fixed-effects model and pooled across studies using a random-effects model. 27 studies met the requirements, including 17 herpes zoster (HZ) studies and ten chickenpox studies. There was an increased risk of stroke after HZ, and this risk decreased over time: relative risk 1.80 (95% CI 1.42-2.29) within 14 days, 1.61 (95% CI 1.43-1.81) within 30 days, 1.45 (95% CI 1.33-1.58) within 90 days, 1.32 (95% CI 1.25-1.39) within 180 days, 1.27 (95% CI 1.15-1.40) at one year and 1.19 (95% CI 0.90-1.59) after one year, with the same trend in the stroke subtype. The risk of stroke after herpes zoster ophthalmicus was higher, with a maximum relative risk of 2.26 (95% CI 1.35-3.78). The risk of stroke after HZ was higher in patients aged around 40 years: relative risk 2.53 (95% CI 1.59-4.02), and similar in men and women. Also, after pooling studies of post-chickenpox stroke, we found that the middle cerebral artery and its branches were most frequently involved (78.2%), with a better prognosis in most patients (83.1%) and less frequent vascular persistence progression (8.9%). In conclusion, the risk of stroke increases after VZV infection, decreasing over time. Post-infection vascular inflammatory changes often occur in the middle cerebral artery and its branches, with a better prognosis in most patients and less frequent persistent progression.


Subject(s)
Chickenpox , Herpes Zoster , Stroke , Male , Humans , Female , Aged , Herpesvirus 3, Human , Chickenpox/complications , Herpes Zoster/complications , Risk , Inflammation
7.
Eur J Neurol ; 30(12): 3819-3827, 2023 12.
Article in English | MEDLINE | ID: mdl-37540821

ABSTRACT

BACKGROUND AND PURPOSE: Prodromal infections are associated with neuromyelitis optica spectrum disorder (NMOSD), but it remains unclear which type of infection has a causal association with NMOSD. We aimed to explore the causal associations between four herpesvirus infections (chickenpox, cold sores, mononucleosis and shingles) and NMOSD, as well as between other types of infections and NMOSD. METHODS: For data on infections, we used the genome-wide association study (GWAS) summary statistics from the 23andMe cohort. For outcomes, we used the GWAS data of participants of European ancestry, including 215 NMOSD patients (132 anti-aquaporin-4 antibody [AQP4-ab]-positive patients and 83 AQP4-ab-negative patients) and 1244 normal controls. Single-nucleotide polymorphism (SNP) identification and two-sample Mendelian randomization (MR) analyses were then performed. RESULTS: In the 23andMe cohort, we identified one SNP for chickenpox (rs9266089 in HLA-B gene), one SNP for cold scores (rs885950 in the POU5F1 gene), one SNP for mononucleosis (rs2596465 in the HCP5 gene), and three SNPs for shingles (rs2523591 in the HLA-B gene; rs7047299 in the IFNA21 gene; rs9260809 in the MICD gene). The association between cold sores and AQP4-ab-positive NMOSD reached statistical significance (odds ratio [OR] 745.318; 95% confidence interval [CI] 22.176, 25,049.53 [p < 0.001, Q < 0.001]). The association between shingles and AQP4-ab-positive NMOSD was also statistically significant (OR 21.073; 95% CI 4.271, 103.974 [p < 0.001, Q < 0.001]). No significant association was observed between other infections and AQP4-ab-positive or AQP4-ab-negative NMOSD. CONCLUSION: These findings suggest there are positive associations between cold sores and shingles and AQP4-ab-positive NMOSD, indicating there may be causal links between herpes simplex virus and varicella-zoster virus infection and AQP4-ab-positive NMOSD.


Subject(s)
Chickenpox , Herpes Labialis , Herpes Zoster , Neuromyelitis Optica , Humans , Neuromyelitis Optica/genetics , Aquaporin 4/genetics , Chickenpox/complications , Genome-Wide Association Study , Herpes Labialis/complications , Mendelian Randomization Analysis , Autoantibodies , Herpes Zoster/complications , HLA-B Antigens
8.
BMC Neurol ; 23(1): 133, 2023 Mar 30.
Article in English | MEDLINE | ID: mdl-36997920

ABSTRACT

BACKGROUND: Polyradiculoneuropathy following infection with varicella zoster virus (VZV) is rare and most of the time, happens in the context of reactivation of latent VZV. We report a case of acute polyradiculoneuropathy following primary infection with VZV marked by atypical clinical features raising the hypothesis of a para-infectious disease. CASE PRESENTATION: We describe a 43-years-old male who developed ataxia, dysphagia, dysphonia, and oculomotor disorders (vertical binocular diplopia and bilateral ptosis) followed by quadriplegia with areflexia which occurred 4 days later. The patient had a history of varicella that occurred 10 days before the onset of these symptoms. Nerve conduction study revealed features consistent with an acute motor-sensory axonal neuropathy (AMSAN). Anti-ganglioside antibodies were negative. Based on clinical presentation and ancillary examination, we retain the Miller Fisher/Guillain-Barré overlap syndrome diagnosis. The patient was treated with high doses of methylprednisolone but the evolution of the disease was nevertheless marked by a complete recovery six weeks after onset of symptoms. CONCLUSION: GBS following varicella is a rare but severe disease occurring most often in adults and marked by greater involvement of the cranial nerves. Its clinical features suggest that it is a para-infectious disease. Antiviral therapy has no effect on the course of the disease but its administration within the first 24 h after the onset of chickenpox in adults can prevent its occurrence.


Subject(s)
Chickenpox , Communicable Diseases , Guillain-Barre Syndrome , Miller Fisher Syndrome , Adult , Male , Humans , Guillain-Barre Syndrome/diagnosis , Guillain-Barre Syndrome/etiology , Guillain-Barre Syndrome/therapy , Chickenpox/complications , Herpesvirus 3, Human , Diplopia/complications , Communicable Diseases/complications
9.
BMC Neurol ; 23(1): 43, 2023 Jan 27.
Article in English | MEDLINE | ID: mdl-36707826

ABSTRACT

BACKGROUND: Ramsay-Hunt syndrome (RHS) due to varicella zoster virus (VZV) infection is commonly reported in individuals aged at least 50 years or immunocompromised individuals. VZV infection may invade the central nervous system (CNS) and cause meningitis or encephalitis, which are more likely to occur in patients with chronic diseases such as diabetes and chronic renal failure. However, cases with VZV-induced concurrent RHS and CNS infections are rare. CASE PRESENTATION: Two young male patients, aged 32 and 43 years, with no underlying disease developed VZV meningitis, followed by RHS involving cranial nerves VII and VIII. Both patients presented with symptoms of peripheral facial palsy, and dizziness accompanied by tinnitus and hearing loss, which appeared several days after the onset of fever and headache. These symptoms were documented as facial neuropathy and sensorineural hearing loss in the electrophysiologic studies. Lymphocyte-dominant pleocytosis and VZV positivity were confirmed from cerebrospinal fluid examination and polymerase chain reaction, respectively. The patients were treated with intravenous acyclovir and oral steroids simultaneously. Following the treatment completion, both patients were relieved of their headaches and fever; however, facial palsy, dizziness, and tinnitus persisted. They were followed up at the outpatient clinic. CONCLUSION: These cases confirmed that RHS and CNS infections can co-exist even in young adults with normal immune function and more importantly, that CNS infection can precede RHS. Since early detection and treatment of RHS improve the prognosis, it is critical to closely monitor patients with VZV meningitis or encephalitis considering the possible superimposition of RHS.


Subject(s)
Chickenpox , Encephalitis , Facial Paralysis , Herpes Zoster Oticus , Herpes Zoster , Meningitis, Viral , Tinnitus , Young Adult , Humans , Male , Herpes Zoster Oticus/complications , Herpes Zoster Oticus/diagnosis , Herpes Zoster Oticus/drug therapy , Chickenpox/complications , Facial Paralysis/drug therapy , Facial Paralysis/etiology , Dizziness/complications , Tinnitus/complications , Herpesvirus 3, Human , Vertigo/complications , Encephalitis/complications , Meningitis, Viral/complications , Meningitis, Viral/diagnosis , Herpes Zoster/complications
10.
BMC Infect Dis ; 23(1): 239, 2023 Apr 18.
Article in English | MEDLINE | ID: mdl-37072696

ABSTRACT

In this case report, we describe two unusual presentations of varicella-zoster virus (VZV) reactivation without rash, a condition known as Zoster Sine Herpete (ZSH). In Case 1, a 58-year-old woman presented with severe right-sided chest pain under her breast that radiated to the ipsilateral back. After the initial workup ruled out cardiac and musculoskeletal etiologies, the characteristic dermatomal distribution of pain made us suspect VZV reactivation. A diagnosis of ZSH was made with positive VZV IgG and IgM serologies and symptomatic relief after famciclovir treatment. In Case 2, a 43-year-old woman presented with a severe headache and resolved sharp right flank pain. She was diagnosed with varicella meningitis after cerebrospinal fluid showed positive VZV DNA. Intravenous acyclovir treatment resulted in symptom resolution. The most common presentation of VZV reactivation is Herpes Zoster, or shingles, making ZSH a frequently missed diagnosis. High clinical suspicion is warranted to prevent life-threatening complications of ZSH.


Subject(s)
Chickenpox , Herpes Zoster , Varicella Zoster Virus Infection , Zoster Sine Herpete , Humans , Female , Middle Aged , Adult , Zoster Sine Herpete/diagnosis , Zoster Sine Herpete/drug therapy , Chickenpox/complications , Herpesvirus 3, Human , Herpes Zoster/complications , Herpes Zoster/diagnosis , Herpes Zoster/drug therapy , Varicella Zoster Virus Infection/complications , Varicella Zoster Virus Infection/diagnosis , Varicella Zoster Virus Infection/drug therapy , Chest Pain/complications , Headache/etiology
11.
Graefes Arch Clin Exp Ophthalmol ; 261(8): 2169-2179, 2023 Aug.
Article in English | MEDLINE | ID: mdl-36949170

ABSTRACT

PURPOSE: While typically affecting older adults and immunocompromised individuals, herpes zoster ophthalmicus (HZO) has been reported with varying manifestations and complications in children. In this review, we evaluate reported cases of pediatric HZO in the literature and discuss the epidemiology, risk factors, clinical presentation, treatment and outcomes. METHODS: A literature search on PubMed, Scopus, and Web of Science databases was performed using the terms "pediatric herpes zoster ophthalmicus" and "herpes zoster ophthalmicus children." Publications that were not specific to HZO or pediatric populations were excluded, as were publications that were not available to review or not published in the English language. RESULTS: Fifty-seven reports describing 130 cases of HZO or HZO-related complications were reviewed. Major risk factors for pediatric HZO included intrauterine exposure to varicella or primary varicella infection at a young age; HZO also occurred in patients who had received varicella vaccination. Both healthy and immunocompromised children were affected, with the majority of affected children being immunocompetent. The diagnosis of HZO is primarily clinical. Children appear to have good vision recovery and resolution of symptoms if they are treated promptly and if they adhere to treatment regimens, except for irreversible vision loss related to uncommon complications such as optic neuritis. CONCLUSION: HZO occurs in both healthy and immunocompromised children. Recognizing this treatable condition is essential for reducing ocular and systemic morbidity. Long-term follow-up and assessments of the impact on health in adulthood are lacking. More systematic study is needed to determine the incidence of HZO in children and appropriate diagnostic and treatment protocols for the care of pediatric patients with HZO.


Subject(s)
Chickenpox , Herpes Zoster Ophthalmicus , Humans , Child , Aged , Herpes Zoster Ophthalmicus/complications , Chickenpox/complications , Herpesvirus 3, Human , Incidence , Morbidity
12.
Rev Esp Enferm Dig ; 115(5): 271-272, 2023 05.
Article in English | MEDLINE | ID: mdl-36148676

ABSTRACT

Vedolizumab is a monoclonal antibody that has demonstrated efficacy and a good safety profile in patients with inflammatory bowel disease. Varicella zoster virus encephalitis is a potentially serious complication not previously described with its use, highlighting the importance of vaccination, as well as early diagnosis and treatment of infections in this type of patients.


Subject(s)
Chickenpox , Encephalitis, Varicella Zoster , Herpes Zoster , Humans , Herpesvirus 3, Human , Herpes Zoster/chemically induced , Herpes Zoster/complications , Encephalitis, Varicella Zoster/complications , Encephalitis, Varicella Zoster/diagnosis , Antibodies, Monoclonal, Humanized/adverse effects , Chickenpox/complications
13.
Reumatismo ; 75(4)2023 Dec 19.
Article in English | MEDLINE | ID: mdl-38115780

ABSTRACT

Idiopathic immune myopathies (IIMs) are autoimmune diseases caused by immune-mediated muscle damage. The etiology remains unclear. Epidemiological and experimental studies, both in animals and humans, hint at viruses as major environmental factors able to trigger aberrant immune responses through many different mechanisms. However, only a few cases of either dermatomyositis or polymyositis following a specific viral infection have been reported in the literature. The objective of this study is to describe the clinical features and the treatment strategy of 2 cases of polymyositis developing shortly after chickenpox and mumps, respectively, and to review the existing literature on the topic. The clinical records of the 2 patients suspected to have developed inflammatory myositis following a viral infection were reviewed. Their clinical history, main laboratory findings, and treatment outcome are presented here. Moreover, a literature search was performed in the PubMed and MEDLINE databases to identify reports describing the association between viral infections and IIMs in patients aged ≥18. The 2 patients reported here developed polymyositis shortly after chickenpox and mumps, respectively, suggesting a causal role for viruses in triggering autoimmunity. Only a few reports published between 1990 and 2020 were found in the literature, possibly linking infections to myositis development. Intravenous immunoglobulin and rituximab were effective for the treatment of viral-triggered polymyositis.


Subject(s)
Autoimmune Diseases , Chickenpox , Dermatomyositis , Mumps , Myositis , Polymyositis , Adult , Humans , Chickenpox/complications , Dermatomyositis/etiology , Mumps/complications , Myositis/etiology , Polymyositis/complications
14.
West Afr J Med ; 40(8): 873-876, 2023 08 28.
Article in English | MEDLINE | ID: mdl-37639575

ABSTRACT

INTRODUCTION: Mpox and Chicken pox have similar presentations, sometimes causing a diagnostic dilemma. Reports have emerged of coinfections, mostly in the central African region. CASE REPORT: Index patient is a 23-year-old female who presented with a 2-week history of exanthematous vesiculopustular rashes which started from her genital and groin area with accompanying vulvar swelling. It was then followed by other similar rashes involving mainly her face and limbs with some on her trunk. There was also an associated high grade continuous fever. Rashes were painful and itchy with associated cervical and axillary lymphadenopathy. Following admission, patient had increasing dysuria with accompanying acute urinary retention due to the discomfort accompanying micturition which was relieved by urethral catheterization and resolved with intravenous infusion and parenteral empirical antibiotics for superimposed bacterial infection. Polymerase chain reaction from her skin lesion sample was positive for both monkey pox and chicken pox. She was also given a course of acyclovir and made an uneventful recovery after 12 days of admission and was discharged. CONCLUSION: We report a rare manifestation of acute urinary retention in a HIV-negative female patient with Mpox and chicken pox co-infection.


INTRODUCTION: La variole du singe et la varicelle ont des présentations similaires, ce qui pose parfois un dilemme diagnostique. Des cas de coinfection ont été signalés, principalement dans la région de l'Afrique centrale. RAPPORT DE CAS: La patiente de référence est une femme de 23 ans qui a présenté pendant deux semaines des éruptions vésiculo-pustuleuses exanthémateuses qui ont commencé dans la région génitale et l'aine, accompagnées d'un gonflement de la vulve. D'autres éruptions similaires ont suivi, touchant principalement le visage et les membres, mais aussi le tronc.Une fièvre élevée et continue a également été associée à ces éruptions. Les éruptions étaient douloureuses et prurigineuses, avec une lymphadénopathie cervicale et axillaire associée. Aprèsson admission, la patiente a présenté une dysurie croissante accompagnée d'une rétention urinaire aiguë due à l'inconfort de la miction, qui a été soulagée par un cathétérisme urétral et résolue par une perfusion intraveineuse et une antibiothérapie parentérale empirique pour une infection bactérienne superposée. La réaction en chaîne de la polymérase à partir de l'échantillon de sa lésion cutanée était positive pour la variole du singe et la varicelle. Elle a également reçu un traitement à l'acyclovir et s'est rétablie sans incident après 12 jours d'admission et a été autorisée à sortir. CONCLUSION: Nous rapportons une manifestation rare de rétention urinaire aiguë chez une femme séronégative atteinte d'une co-infection par la variole du singe et la varicelle. Mots-clés: Mpox, Varicelle, Nigeria, Épidémie, Rétention urinaire, Lymphadénopathie.


Subject(s)
Chickenpox , Coinfection , Exanthema , Mpox (monkeypox) , Urinary Retention , Female , Humans , Urinary Retention/etiology , Chickenpox/complications , Coinfection/diagnosis , Coinfection/drug therapy , Anti-Bacterial Agents/therapeutic use
15.
J Clin Gastroenterol ; 56(9): 798-804, 2022 10 01.
Article in English | MEDLINE | ID: mdl-35152238

ABSTRACT

BACKGROUND: Patients with inflammatory bowel disease (IBD) are at an increased risk of infections, including vaccine-preventable diseases (VPDs). The aim of this study was to explore the inpatient prevalence of VPD in patients with IBD, as well as inpatient outcomes. METHODS: Retrospective study using the 2013-2017 Nationwide Inpatient Sample databases. All patients 18 years of age or older with International Classification of Diseases, Ninth and 10th Revisions , Clinical Modification (ICD-9/10 CM) codes for IBD were included, as well as patients with VPDs as a principal diagnostic code. The primary outcome was the occurrence and odds of VPD in patients with IBD compared with patients with no IBD. Secondary outcomes were inpatient mortality, morbidity, and economic burden compared with patients with IBD and non-vaccine-preventable infections (VPIs). Multivariate regression yielded adjusted odds ratios. RESULTS: Of 1,622,245 (0.9%) patients with a diagnosis of IBD, 3560 (0.2%) had associated VPDs, while 131,150 patients had non-VPI (8.1%). The most common VPDs were influenza, herpes zoster (HZ), pneumococcal pneumonia, and varicella. Only HZ and varicella had increased odds of occurrence in patients with IBD of all ages. Patients with IBD 65 years of age or older had increased odds of VPD compared with patients under 65 years. Patients with IBD and associated VPD had higher odds of intensive care unit stay, systemic inflammatory response syndrome, and multiorgan failure compared with patients with IBD and non-VPI. CONCLUSIONS: VPDs represent a clinically relevant cause of infectious disease-related hospital admissions in patients with IBD. Patients with IBD are at increased risk for hospitalization due to HZ and varicella. Those hospitalized for VPD have higher morbidity compared with patients with IBD and non-VPI. These findings echo the importance of instituting optimal immunization schedules in patients with IBD, particularly in patients 65 years or older.


Subject(s)
Chickenpox , Inflammatory Bowel Diseases , Vaccine-Preventable Diseases , Adolescent , Adult , Aged , Chickenpox/complications , Chronic Disease , Hospitalization , Humans , Inflammatory Bowel Diseases/complications , Inflammatory Bowel Diseases/epidemiology , Retrospective Studies
16.
Epidemiol Infect ; 150: e127, 2022 06 21.
Article in English | MEDLINE | ID: mdl-35726529

ABSTRACT

The study aimed to explore the relationship between eosinophils and the prognosis of varicella in adults. We retrospectively reviewed the medical records of patients who were hospitalised in The Fifth People's Hospital of Suzhou with a diagnosis of adult varicella during the period between 1 January 2012 and 31 December 2020. Of the 359 patients, 228 (63.51%) had eosinopenia. The proportion of patients with mild type disease was significantly lower in the eosinopenia group than that in the non-eosinopenia group (50.44% vs. 65.65%, P = 0.006). The proportion of the patients with common type disease was significantly higher in the eosinopenia group than that in the non-eosinopenia group (39.47% vs. 28.24%, P = 0.039). The proportion of the patients with severe type disease was higher in the eosinopenia group, although the difference did not reach statistical significance (10.09% vs. 6.11%, P = 0.243). The rates of high fever (47.81% vs. 32.82%, P = 0.008; relative risk (RR) 1.296, 95% confidence interval (CI) 1.091-1.540), headache (43.42% vs. 22.14%, P < 0.001; RR 1.415, 95% CI 1.233-1.623), anorexia (53.51% vs. 35.88%, P = 0.001; RR 1.367, 95% CI 1.129-1.655) and complications (82.89% vs. 64.12%, P < 0.001; RR 2.106, 95% CI 1.460-3.038) were also significantly higher in the eosinopenia group. Among the complications, the liver injury and skin infection were more serious in the eosinopenia group. The disease course was significantly longer in the eosinopenia group than that in the non-eosinopenia group (9.43 ± 1.89 days vs. 8.73 ± 1.25 days, P < 0.001). The improvement rate of liver injury in the recovery period was lower in the eosinopenia group than that in the non-eosinopenia group (35.38% vs. 50%, P = 0.012). The study found that adult varicella patients with eosinopenia had a more serious condition, a higher morbidity of complications and a slower recovery. Blood eosinophils can be used as a new predictor of the severity of adult varicella.


Subject(s)
Agranulocytosis , Chickenpox , Adult , Chickenpox/complications , Chickenpox/epidemiology , Eosinophils , Humans , Leukocyte Count , Retrospective Studies
17.
BMC Infect Dis ; 22(1): 215, 2022 Mar 03.
Article in English | MEDLINE | ID: mdl-35241009

ABSTRACT

BACKGROUND: Visceral disseminated varicella zoster virus (VZV) infections frequently affect immunocompromised patients. Diabetes mellitus has been associated with VZV infection, and most cases of disseminated infection involve patients with poorly controlled blood glucose levels. It initially presents as severe abdominal pain, which is evaluated as an acute abdomen, however, the cause is typically unidentified due to unremarkable computed tomography (CT) findings. We report a case of visceral disseminated VZV infection in a patient with well-controlled diabetes mellitus with fat stranding around the celiac and superior mesenteric artery on CT. CASE PRESENTATION: A 61-year-old Japanese woman with well-controlled diabetes mellitus presented to the emergency department with severe abdominal pain that gradually worsened. She had stable vital signs and skin rashes, suggestive of varicella. Abdominal CT showed fat stranding around the celiac and superior mesenteric arteries. The patient tested positive for the VZV antigen and was diagnosed with a visceral disseminated VZV infection. Acyclovir was administered, and the patient was discharged on the 14th day. CONCLUSIONS: Visceral disseminated VZV infection may affect patients with well-controlled diabetes mellitus and causes acute abdomen. Periarterial fat stranding on CT is associated with abdominal pain due to visceral disseminated VZV infection.


Subject(s)
Abdomen, Acute , Chickenpox , Diabetes Mellitus , Herpes Zoster , Varicella Zoster Virus Infection , Chickenpox/complications , Female , Herpes Zoster/complications , Herpes Zoster/diagnosis , Herpes Zoster/drug therapy , Herpesvirus 3, Human , Humans , Middle Aged , Varicella Zoster Virus Infection/complications , Varicella Zoster Virus Infection/diagnosis
18.
Am J Dermatopathol ; 44(7): e75-e78, 2022 Jul 01.
Article in English | MEDLINE | ID: mdl-35311755

ABSTRACT

ABSTRACT: We present a case of a 55-year-old man with a rash on his right foot that was biopsied and diagnosed as a Varicella Zoster virus infection with an accompanying positive immunohistochemical study with antiviral antibodies. He concomitantly suffered from a Varicella Zoster virus meningitis. The skin biopsies not only showed clear histologic signs of viral cytopathic effects but also showed intercellular IgG and C3 intraepidermal staining by direct immunofluorescence study, findings which are typically consistent with pemphigus vulgaris. However, the patient did not have any history of pemphigus; there was no mucosal involvement, and serum antibodies to desmoglein 1 and 3 were negative. After discharge, the patient continued to have right-sided foot pain, and he continued the acyclovir treatment.


Subject(s)
Chickenpox , Herpes Zoster , Pemphigus , Varicella Zoster Virus Infection , Acyclovir/therapeutic use , Antiviral Agents/therapeutic use , Chickenpox/complications , Herpes Zoster/complications , Herpes Zoster/drug therapy , Herpesvirus 3, Human , Humans , Male , Middle Aged , Pemphigus/pathology , Varicella Zoster Virus Infection/complications , Varicella Zoster Virus Infection/drug therapy
19.
Acta Paediatr ; 111(5): 935-939, 2022 05.
Article in English | MEDLINE | ID: mdl-35178772

ABSTRACT

AIM: In previously healthy subjects, primary varicella presents with a distinctive vesicular rash that is more intense on the trunk and head than on the extremities. However, an atypical presentation may occasionally develop. We aimed at systematically assessing the characteristics of cases affected by atypical primary varicella rash. METHODS: The United States National Library of Medicine, Excerpta Medica and Web of Science databases were reviewed, without date or language restrictions. Articles were eligible if reporting previously healthy and immunocompetent subjects with a primary varicella rash (i.e., a photo-localised primary varicella or skin inflammation-associated primary varicella). RESULTS: Thirty-eight reports providing information on 59 cases of atypical primary varicella were identified. Twenty-four cases (median 8.5 years of age, 19 females) were photo-localised and 35 (median 4.8 years of age, 15 females) were associated with pre-existing skin inflammation (including cast occlusion, diaper irritation, operative sites, burns, insect bites, vaccinations or pre-existing skin disease). The skin rash was monomorphic and without a "starry sky" appearance. CONCLUSION: Primary varicella may have a modified presentation in areas of irritation such as sun exposure or pre-existing inflammation. There is a need for a wider awareness of these modulators of varicella rash.


Subject(s)
Chickenpox , Exanthema , Adolescent , Adult , Chickenpox/complications , Exanthema/etiology , Female , Herpesvirus 3, Human , Humans , Inflammation , Skin , Young Adult
20.
J Pediatr Hematol Oncol ; 43(5): e711-e714, 2021 07 01.
Article in English | MEDLINE | ID: mdl-33625075

ABSTRACT

A 2.5-year-old boy presented to his pediatrician with progressive pallor, asthenia, fever, splenomegaly, and hematomas. Leukemia was suspected, and a bone marrow aspirate confirmed acute lymphoblastic leukemia. Before chemotherapy induction, the child developed a vesicular rash and was diagnosed clinically with chickenpox. Acyclovir treatment was initiated immediately, whereas induction chemotherapy was postponed by 10 days. At the time of chickenpox resolution, a spontaneous partial recovery of his blood counts and a 50% decrease of blastic bone marrow infiltration were noted. After a brief nonsystematic review, we discuss the potential beneficial effect of acyclovir and chickenpox infection in children with leukemia.


Subject(s)
Acyclovir/therapeutic use , Antiviral Agents/therapeutic use , Chickenpox/complications , Chickenpox/drug therapy , Precursor Cell Lymphoblastic Leukemia-Lymphoma/complications , Child, Preschool , Herpesvirus 3, Human/drug effects , Humans , Male , Precursor Cell Lymphoblastic Leukemia-Lymphoma/pathology , Remission, Spontaneous
SELECTION OF CITATIONS
SEARCH DETAIL